GEP-NET
Oncology·MeSH: Gastro-enteropancreatic neuroendocrine tumor
4 drugs in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Phase 1(1)
| Drug | Company |
|---|---|
| ryz401 | RayzeBio, Inc. (RYZB) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| ryz101 | RayzeBio, Inc. (RYZB) |
Compare drugs
Frequently asked questions
How many drugs are in development for GEP-NET?
BioSniper tracks 4 drugs in development for GEP-NET across 1 company.
How many clinical trials target GEP-NET?
There are 3 clinical trials targeting GEP-NET tracked by BioSniper.
Deep-dive into GEP-NET
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis